61990-51-0 Usage
Uses
Used in Pharmaceutical Industry:
4-acetamidobenzoic acid, compound with 1-(dimethylamino)propan-2-ol (1:1) is used as an active pharmaceutical ingredient for the development of antiviral drugs. It serves as a key component in Inosine pranobex, an immunostimulant that acts as an analog of thymus hormones, enhancing the body's immune response against viral infections.
Used in Antiviral Applications:
In the field of antiviral research and treatment, 4-acetamidobenzoic acid, compound with 1-(dimethylamino)propan-2-ol (1:1) is utilized for its immunostimulant properties. It does not directly target viral particles but instead boosts the immune system's ability to combat viral infections, making it a valuable asset in the development of antiviral therapies.
Used in Drug Delivery Systems:
Similar to gallotannin, 4-acetamidobenzoic acid, compound with 1-(dimethylamino)propan-2-ol (1:1) can also be incorporated into novel drug delivery systems to improve its bioavailability and therapeutic outcomes. By employing various organic and metallic nanoparticles as carriers, the compound's delivery and efficacy can be enhanced, allowing for more effective treatment of viral infections.
Check Digit Verification of cas no
The CAS Registry Mumber 61990-51-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,9,9 and 0 respectively; the second part has 2 digits, 5 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 61990-51:
(7*6)+(6*1)+(5*9)+(4*9)+(3*0)+(2*5)+(1*1)=140
140 % 10 = 0
So 61990-51-0 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO3.C5H13NO/c1-6(11)10-8-4-2-7(3-5-8)9(12)13;1-5(7)4-6(2)3/h2-5H,1H3,(H,10,11)(H,12,13);5,7H,4H2,1-3H3
61990-51-0Relevant academic research and scientific papers
Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases
-
Page/Page column 5, (2008/06/13)
The invention is directed to compositions and methods which permit the oral use of adenosine and adenosine phosphates for cardiovascular applications such as pulmonary artery hypertension, cardiac failure and other diseases. Certain compositions in accord
